HDFC Nifty Midcap 150 Index Fund
Glenmark Pharmaceuticals Limited · NSE
24,771 sh · ₹5.53 Cr
HDFC Mid Cap Fund
2.9% of their portfolio
₹2,995.25 Cr
1,34,08,183 sh
ICICI Prudential Arbitrage Fund
0.8% of their portfolio
₹276.95 Cr
12,39,750 sh
SBI Arbitrage Opportunities Fund
56.0% of their portfolio
₹261.87 Cr
11,72,250 sh
HDFC Large and Mid Cap Fund
78.0% of their portfolio
₹234.12 Cr
10,48,046 sh
HDFC Mutual Fund (scheme HDFCGR)
18.0% of their portfolio
₹197.71 Cr
8,85,046 sh
Nippon India Arbitrage Fund
1.0% of their portfolio
₹173.07 Cr
7,74,750 sh
HDFC Manufacturing Fund
1.5% of their portfolio
₹156.37 Cr
7,00,000 sh
Aditya Birla Sun Life Arbitrage Fund
0.5% of their portfolio
₹133.08 Cr
6,03,750 sh
HDFC Mutual Fund (scheme HDFCAR)
48.0% of their portfolio
₹119.21 Cr
5,33,625 sh
HDFC Multi Cap Fund
45.0% of their portfolio
₹91.67 Cr
4,10,341 sh
HDFC Pharma and Healthcare Fund
2.6% of their portfolio
₹76.15 Cr
3,40,887 sh
Nippon India Nifty Pharma ETF
3.4% of their portfolio
₹57.48 Cr
2,57,291 sh
FIIs raised their stake +0.5pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
HDFC Nifty Midcap 150 Index Fund
Glenmark Pharmaceuticals Limited · NSE
24,771 sh · ₹5.53 Cr
SBI Nifty 500 Index Fund
Glenmark Pharmaceuticals Limited · NSE
5,881 sh · ₹1.31 Cr
SBI Nifty Midcap150 ETF
Glenmark Pharmaceuticals Limited · NSE
468 sh · ₹10.45 L
HDFC Pharma and Healthcare Fund
Glenmark Pharmaceuticals Limited · NSE
3,40,887 sh · ₹76.15 Cr
HDFC Large and Mid Cap Fund
Glenmark Pharmaceuticals Limited · NSE
10,48,046 sh · ₹234.12 Cr
Nippon India Nifty Midcap 150 Index Fund
Glenmark Pharmaceuticals Limited · NSE
98,862 sh · ₹22.08 Cr
ICICI Prudential Retirement Fund - Hybrid Aggressive Plan
Glenmark Pharmaceuticals Limited · NSE
42,111 sh · ₹9.41 Cr
SBI Nifty Midcap 150 Momentum 50 ETF
Glenmark Pharmaceuticals Limited · NSE
937 sh · ₹20.93 L
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
40 announcements on record for this company.
Parag Parikh Mutual Fund (scheme PPAF)
0.5% of their portfolio
₹12.40 Cr
55,500 sh
Promoter holding by quarter: Jun 2025 46.6%, Sep 2025 46.6%, Dec 2025 46.6%, Mar 2026 46.6%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +1.1pp
FII holding by quarter: Jun 2025 20.6%, Sep 2025 20.7%, Dec 2025 19.2%, Mar 2026 20.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.8pp
DII holding by quarter: Jun 2025 17.6%, Sep 2025 18.6%, Dec 2025 20.1%, Mar 2026 19.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −1.1pp
MF holding by quarter: Jun 2025 15.6%, Sep 2025 16.3%, Dec 2025 17.9%, Mar 2026 16.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
HDFC Mid Cap Fund
Glenmark Pharmaceuticals Limited · NSE
1,34,08,183 sh · ₹2,995.25 Cr
HDFC Mutual Fund (scheme HDFCGR)
Glenmark Pharmaceuticals Limited · NSE
8,85,046 sh · ₹197.71 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 46.6%, Sep 2025 46.6%, Dec 2025 46.6%, Mar 2026 46.6%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +1.1pp
FII holding by quarter: Jun 2025 20.6%, Sep 2025 20.7%, Dec 2025 19.2%, Mar 2026 20.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.8pp
DII holding by quarter: Jun 2025 17.6%, Sep 2025 18.6%, Dec 2025 20.1%, Mar 2026 19.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −1.1pp
MF holding by quarter: Jun 2025 15.6%, Sep 2025 16.3%, Dec 2025 17.9%, Mar 2026 16.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
40 announcements on record for this company.